Related references
Note: Only part of the references are listed.Biological and clinical consequences of NPM1 mutations in AML
E. M. Heath et al.
LEUKEMIA (2017)
NPM1 Mutant Mediated PML Delocalization and Stabilization Enhances Autophagy and Cell Survival in Leukemic Cells
Qin Zou et al.
THERANOSTICS (2017)
PI3K signaling in cancer: beyond AKT
Evan C. Lien et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases
Samuel J. Rodgers et al.
BIOSCIENCE REPORTS (2017)
INPP4B is an oncogenic regulator in human colon cancer
S. T. Guo et al.
ONCOGENE (2016)
Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases
Matthew J. Eramo et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Nucleophosmin: from structure and function to disease development
Joseph K. Box et al.
BMC MOLECULAR BIOLOGY (2016)
Nucleophosmin Mutants Promote Adhesion, Migration and Invasion of Human Leukemia THP-1 Cells through MMPs Up-regulation via Ras/ERK MAPK Signaling
Jingrong Xian et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia
Brunangelo Falini et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2015)
Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML
Sewa Rijal et al.
BLOOD (2015)
Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling
Hongzhao Li et al.
CELLULAR SIGNALLING (2015)
PI3K and AKT: Unfaithful Partners in Cancer
Seraina Faes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia
I. Dzneladze et al.
LEUKEMIA (2015)
Phosphoinositide signaling in cancer: INPP4B Akt(s) out
John F. Woolley et al.
TRENDS IN MOLECULAR MEDICINE (2015)
INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency
Thanh-Trang T. Vo et al.
CANCER DISCOVERY (2015)
INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor
Satoshi Kofuji et al.
CANCER DISCOVERY (2015)
SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
Jessica A. Gasser et al.
MOLECULAR CELL (2014)
Acute myeloid leukemia with DNMT3A mutations
Yunlong Li et al.
LEUKEMIA & LYMPHOMA (2014)
Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics
Antonia Cagnetta et al.
LEUKEMIA RESEARCH (2014)
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells
Joshua P. Plotnik et al.
NUCLEIC ACIDS RESEARCH (2014)
Determinants of the tumor suppressor INPP4B protein and lipid phosphatase activities
Sandra M. Lopez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
AKT-ing out: SGK kinases come to the fore: Figure 1
Larissa S. Moniz et al.
BIOCHEMICAL JOURNAL (2013)
Role of the inositol polyphosphate-4-phosphatase type II Inpp4b in the generation of ovarian teratomas
Ashwini Balakrishnan et al.
DEVELOPMENTAL BIOLOGY (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia
Roel Polak et al.
BLOOD (2012)
Acute myeloid leukemia with mutated nucleophosmin (NPM1): Any hope for a targeted therapy?
Brunangelo Falini et al.
BLOOD REVIEWS (2011)
Decreased Expression and Androgen Regulation of the Tumor Suppressor Gene INPP4B in Prostate Cancer
Myles C. Hodgson et al.
CANCER RESEARCH (2011)
Second AKT: The rise of SGK in cancer signalling
Maressa A. Bruhn et al.
GROWTH FACTORS (2010)
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
Sophie Park et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Dephosphorylation of Nucleophosmin by PP1β Facilitates pRB Binding and Consequent E2F1-dependent DNA Repair
Chiao Yun Lin et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
Clare G. Fedele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
Christina Gewinner et al.
CANCER CELL (2009)
AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
Krishna M. Vasudevan et al.
CANCER CELL (2009)
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias
Brunangelo Falini et al.
HAEMATOLOGICA (2007)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
Brunangelo Falini et al.
BLOOD (2007)
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
Brunangelo Falini et al.
BLOOD (2006)
Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3
Maude Tessier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin
H Quentmeier et al.
LEUKEMIA (2005)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment
CE Foulds et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling
ME Ross et al.
BLOOD (2003)
Share Paper
